PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹5,495 Cr | ₹4,720 Cr | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr |
What is the latest Total Debt ratio of PIRAMAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹5,495 Cr |
| Mar2025 | ₹4,720 Cr |
| Mar2024 | ₹4,559 Cr |
| Mar2023 | ₹5,505 Cr |
| Mar2022 | ₹4,023 Cr |
How is Total Debt of PIRAMAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,495 Cr | 16.42 | |
| Mar2025 | ₹4,720 Cr | 3.54 | |
| Mar2024 | ₹4,559 Cr | -17.18 | |
| Mar2023 | ₹5,505 Cr | 36.82 | |
| Mar2022 | ₹4,023 Cr | - | |
Compare Total Debt of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹25,887.1 Cr | 0.6% | -2.4% | -3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 0.6% |
-2.4% |
-3.7% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses